Executing a Complex Phase III Diabetes Cardiovascular Outcomes Trial in a High-Risk Population Cardiovascular outcomes trials (CVOTs) in type 2 diabetes present a unique combination of clinical, operational, and regulatory complexity, particularl...
Join Julius Clinical at American Diabetes Association’s (ADA’s) Scientific Sessions 2026 in New Orleans from June 5-8, 2026. Meet our cardiometabolic experts at the 2026 Scientific Sessions to discover how Julius Clinical supports efficient, ...
Join Julius Clinical at the Epilepsy Foundation Pipeline Conference in Leesburg, Virginia from June 18-19, 2026. Meet our neuroscience experts at the Epilepsy Foundation Pipeline Conference 2026 to discover how Julius Clinical supports efficient,...
Join Julius Clinical at BIO 2026 in San Diego from June 22-25, 2026. Connect with Julius Clinical and P95 to explore how our combined scientific, clinical, epidemiological, and real-world evidence expertise supports smarter decision-making across...
Join Julius Clinical at the ENCALS Meeting 2026 in Madrid from June 24-26, 2026. Meet our neuroscience experts at the ENCALS (European Networks to Cure ALS) Meeting 2026 to discover how Julius Clinical supports efficient, high-quality clinical tr...
Join Julius Clinical at Alzheimer's Association International Conference in London from July 12-15, 2026. Meet our neuroscience experts at AAIC to discover how Julius Clinical supports efficient, high-quality clinical trials across complex neurol...
The GRIPonMASH consortium has reached a significant milestone in screening individuals at risk of metabolic dysfunction-associated steatotic liver disease (MASLD). Julius Clinical is proud to contribute to this achievement.The GRIPonMASH conso...
The Netherlands, 09 February 2026Ubiquitous in real-world data (RWD) projects, Electronic Medical Record (EMR) and Electronic Health Record (EHR) data is making its way slowly but surely into clinical trials, and the possibilities appear endle...
500+ person global organization spans 25+ countries with operations across North America, Europe, Africa, Latin America, and Asia-Pacific
Zeist, The Netherlands – September 23, 2025 – Julius Clinical, a leading clinical Contract Research Organization (CRO) with deep therapeutic expertise in CNS and Cardiometabolic diseases, is pleased to announce the appointment of Bassem Saleh ...
"*" indicates required fields
"*" indicates required fields
P95 and Julius Clinical have merged to form a leading global, full-service clinical research organization (CRO) with integrated expertise across neuroscience, cardio-renal-metabolic, and infectious diseases and vaccines. Read more here.
